Integrated computational and experimental identification of p53, KRAS and VHL mutant selection associated with CRISPR-Cas9 editing
Sinha, S.; Barbosa, K. O.; Cheng, K.; Leiserson, M. D.; Wilson, D. M.; Ryan, B. M.; Ronai, Z. A.; Lee, J. S.; Deshpande, A.; Ruppin, E.
Show abstract
Recent studies have reported that CRISPR-Cas9 gene editing induces a p53-dependent DNA damage response in primary cells, which may select for cells with oncogenic p53 mutations11,12. It is unclear whether these CRISPR-induced changes are applicable to different cell types, and whether CRISPR gene editing may select for other oncogenic mutations. Addressing these questions, we analyzed genome-wide CRISPR and RNAi screens to systematically chart the mutation selection potential of CRISPR knockouts across the whole exome. Our analysis suggests that CRISPR gene editing can select for mutants of KRAS and VHL, at a level comparable to that reported for p53. These predictions were further validated in a genome-wide manner by analyzing independent CRISPR screens and patients tumor data. Finally, we performed a new set of pooled and arrayed CRISPR screens to evaluate the competition between CRISPR-edited isogenic p53 WT and mutant cell lines, which further validated our predictions. In summary, our study systematically charts and points to the potential selection of specific cancer driver mutations during CRISPR-Cas9 gene editing.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Interrogation of cancer gene dependencies reveals novel paralog interactions of autosome and sexchromosome encoded genes 97%
- Genetic dependencies associated with transcription factor activities in human cancer cell lines 96%
- DROSHA, DICER and Damage-Induced long ncRNA control BMI1-dependent transcriptional repression at DNA double-strand break 96%
Similar papers in this journal
- Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal 96%
- Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes 96%
- Modelling asymmetric count ratios in CRISPR screens to decrease experiment size and improve phenotype detection 96%
Similar papers in this journal
Similar papers in this journal
- Linking candidate causal autoimmune variants to T cell networks using genetic and epigenetic screens in primary human T cells. 96%
- Human genetic diversity modifies therapeutic gene editing off-target potential 96%
- Saturation Genome Editing Resolves the Functional Spectrum of Pathogenic VHL Alleles 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.